The global burden and risk factors of common mental disorders in pregnant women: a systematic review and meta-analysis Authors: Techilo Tinsae, Setegn Fentahun, Girmaw Medfu, Shegaye Shumet, Gebresilassie Tadesse, Selam Koye, Fantahun Andualem, Girum Nakie, Gidey Rtbey, Wondale Getinet Published: 2026 ABSTRACT AbstractDuring pregnancy, mental health conditions are a major health concern across the globe. Common mental disorders have complex effects on the health of the mother and fetus, as well as long-lasting social and economic repercussions. Hence, this study aimed to assess the worldwide pooled prevalence and risk factors of common mental disorders in pregnant women. We searched published papers using major databases, including Embase, PubMed, PsycINFO, Web of Science, Google Scholar, and HINARI, for studies on the prevalence and risk factors of common mental disorders published up to January 2024. The research teams used the Newcastle–Ottawa Quality Assessment Scale to assess the quality of each study. Two independent researchers screened and extracted the data. The analysis conducted using STATA statistical software version 11. The global estimated pooled prevalence and risk factors of common mental disorders in pregnant women were assessed using a random effect model. The heterogeneity of the included studies was evaluated using the I2 statistic. The researchers assessed the publication bias using the funnel plot and Egger’s statistical test. The studies comprised eighteen studies with 17,380 pregnant women. The global pooled prevalence of common mental disorders in pregnant women was 31.59% (95% CI: 23.74–39.43). Subgroup analysis estimated the prevalence of common mental disorders in Africa (30.30%; 95% CI: 20.95–39.65), Asia (22.96%; 95% CI: 13.12–32.78), and South America (40.30%; 95% CI: 23.92–59.15). The risk factors considered included a family history of mental illness, chronic medical conditions, intimate partner violence, unplanned pregnancy, emotional violence, and a history of abortion. However, only intimate partner violence (POR = 2.63; 95% CI: 1.12, 6.17) was found to be significantly associated with common mental disorders among pregnant women. This study reveals a high global burden of common mental disorders among pregnant women, with regional variations. Intimate partner violence was found to be a significant risk factor. To mitigate its impact, integrating routine mental health screening and intimate partner violence prevention should be made into maternal healthcare services.Keywords: Common mental disorder, Mental health distress, Pregnant women, Prenatal women, WomenSubject terms: Health care, Medical research Introduction Mental health disorders are significant public health concerns during pregnancy, as they can adversely affect both the mother and the developing child1–5. These conditions, including depression, anxiety, and other common mental health conditions, may lead to complications such as poor maternal self-care, inadequate prenatal care, increased risk of obstetric complications, and negative birth outcomes6–10. Additionally, maternal mental health disorders can have long-term consequences on the child’s emotional, cognitive, and behavioral development11–13. Addressing these concerns through early identification, effective interventions, and supportive healthcare policies is crucial to improving maternal and child well-being. Common Mental Disorders (CMDs) are defined as a group of mental health conditions that frequently occur during pregnancy and are characterised by significant emotional distress, impairment in daily functioning, and impact on maternal and neonatal outcomes14,15. CMDs are characterised by psychological distress indicators such as anxiety, despair, and suicidal ideation, with additional symptoms including irritability, insomnia, fatigue, nonspecific somatic complaints, and memory problems, which can significantly affect daily functioning and interfere with routine activities16,17. The presence of CMDs during pregnancy can significantly impact maternal healthcare utilisation, leading to a reduced likelihood of seeking timely and adequate antenatal care18–20. This, in turn, increases the risk of obstetric complications and adverse child health outcomes21–23. Pregnant individuals experiencing CMDs, such as depression and anxiety, may be less likely to adhere to recommended prenatal checkups, nutritional guidelines, and medical advice, which can contribute to an increased risk of complicated deliveries24–26. Furthermore, poor maternal mental health is associated with negative neonatal outcomes, including low birth weight, preterm delivery, and a higher likelihood of neonatal and infant mortality26–29. Additionally, undiagnosed or untreated CMDs during pregnancy may contribute to the development of postpartum mental health conditions, such as postnatal psychosis and self-harm which can further affect maternal-infant bonding and caregiving practices11,30,31. These early-life stressors and disruptions in maternal care may lead to long-term behavioral, emotional, and cognitive challenges in children, potentially impacting their overall well-being and development32,33. Therefore, addressing maternal mental health during pregnancy is essential to improving both maternal and child health outcomes. In developed countries, CMDs are a prevalent concern among pregnant women, with an estimated 7% to 15% experiencing some form of mental health condition during pregnancy, In contrast, in low- and middle-income countries, the burden of mental health distress is higher, ranging from 15.6% to 19.8% of pregnant women experiencing such conditions1,26,34. Among these, depression and anxiety are the most commonly reported disorders, affecting approximately 12% and 13% of pregnant women, respectively35. In mental health cases, these conditions do not occur in isolation; some women may experience both depression and anxiety simultaneously, further compounding the psychological distress and potential adverse effects on maternal and fetal health36,37. The prevalence of these disorders can vary based on factors such as socioeconomic status, exposure to stressful life events, lack of social support, and pre-existing mental health conditions23,38,39. Given their significant impact on maternal well-being, pregnancy outcomes, and child development, early identification and intervention strategies are critical in mitigating the effects of CMDs during pregnancy. According to the World Health Organization (WHO), the prevalence of anxiety disorders among women varies across regions, ranging from 2.9% in the Western Pacific Region to 5.8% in the Region of the Americas. Similarly, the prevalence of depressive disorders ranges from 3.6% in the Western Pacific Region to 5.4% in the African region14. CMDs can have profound effects on daily functioning, workplace productivity, and interpersonal relationships within family and social contexts40. Young individuals with CMD often experience increased socioeconomic vulnerabilities, leading to diminished productivity, social isolation, and a greater need for healthcare services41. Among women, CMDs can have particularly severe consequences for the mother-child attachment, the broader family unit, and society at large42. Maternal mental health disorders during pregnancy are associated with adverse obstetric and neonatal outcomes, such as low birth weight, preterm births, negative birth experiences, and impaired mother-infant bonding. These disorders can also exacerbate marital conflicts, resulting in family instability42,43. Recent systematic reviews highlight the high global prevalence of CMD, particularly among pregnant women. In high-income countries, prevalence rates of CMD range between 10% and 15%, whereas in low- and middle-income countries (LMICs), ranging from 10 to 41%44,45. Cohort studies have identified several risk factors for CMD among women, including smoking, experiencing abnormal vaginal discharge, chronic physical illnesses, being married as opposed to single, higher baseline psychological symptom scores, and poverty-related factors such as low income and financial struggles46. A systematic review and meta-analysis of CMD among women revealed prevalence rates ranging from 9.6 to 69.3%47. Risk factors identified include unemployment, low income, being a housewife, smoking, low educational attainment, single, divorced, or widowed status, and poor self-rated health48. Despite their substantial and long-term impacts, the existing evidence remains fragmented and insufficient to inform the development of comprehensive prevention and treatment strategies. The prevalence of CMDs varies ranging from 6.2 to 71%49,50. Therefore, this systematic review and meta-analysis was undertaken to synthesize the available evidence and provide robust estimates of the burden of common mental disorders among pregnant women. Mental health problems among pregnant women remain a critical yet neglected public health concern, contributing to health-related challenges within this demographic. While research studies have assessed the prevalence of CMD in pregnant women, findings remain inconsistent. To date, no comprehensive systematic review or meta-analysis conducted to synthesis the pooled prevalence and associated risk factors of CMD among pregnant women globally. The objective of this systematic review and meta-analysis was to address this gap by generating evidence-based pooled estimates of the global prevalence of common mental disorders and identifying associated risk factors among pregnant women worldwide. Methods and materials Population The study population included all pregnant women without restrictions on age, ethnicity, or geographical location. Outcomes The primary outcomes of this study were the prevalence and associated risk factors that contribute to common mental disorders during pregnancy. Study design This review included observational research, including cross-sectional studies, cohort studies, and case-control studies. Searching strategies Two authors (TT and SS) independently searched literature. This review article reported the following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Related published articles were searched in online public databases such as Embase, PubMed, PsycINFO, Web of Science, Google Scholar, and HINARI, reporting on the prevalence and risk factors of common mental disorders in pregnant women worldwide until January 2024. The research team designed this search strategy in accordance with Medical Subject Headings (MeSH) and employed systematically arranged keywords to identify relevant research articles. The search terms were used separately and in combination using Boolean operators like “OR” or “AND.” The search approach used to retrieve related articles was as follows. ((“Pregnancy”[MeSH] OR “Pregnant Women” OR prenatal, “antenatal”, OR “gestational” OR “expectant mothers” OR “maternal”) AND (“Mental Disorders”[MeSH] OR “Common Mental Disorders” OR “CMD” OR “Anxiety” OR “Anxious” OR “Depression” OR “Dysthymia” OR “generalized anxiety disorder” OR “panic disorder” OR “Phobia” OR “social anxiety disorder” OR “obsessive-compulsive disorder” OR “mental disorder” OR “mental health” OR “psychological stress” OR “life stress” OR “mental health problem” OR “emotional stress” OR “postpartum depression” OR “perinatal depression” OR “stress disorders” OR “psychological distress”)) AND (“Cross-Sectional Studies”[MeSH] OR “Survey” OR “Cross-sectional studies” OR “Prevalence” OR “Frequency” OR “Cross-sectional” OR “Observational” OR “Cohort studies” [MeSH] OR “prospective studies”)). Eligibility criteria Inclusion The research team included published articles from countries around the world. Original data indicating the frequency of common mental disorders and risk factors in pregnant women from observational studies (cross-sectional, case-control, and cohort studies) and only articles published in the English language were included. Pregnant women who had common mental disorders were the study population in this study. Published pieces of literature available until January 2024 incorporated. Exclusion The researchers excluded published studies from this study, including incomplete studies, records lacking pertinent outcomes, editorial remarks, correspondence to the editor, systematic reviews, and qualitative research. Data extraction methods and quality assessment To prevent duplication, all the papers were exported to the EndNote citation manager, Version number: Endnote X7 (https://endnote.com). A Microsoft Excel assessment format was used to determine each study’s eligibility for inclusion. The data extraction was conducted using Microsoft Excel Version number: Microsoft Excel 2010 (https://www.microsoft.com/en-us/microsoft-365/excel). The following details were taken from the extracted data: the author’s name, the publication years, the study population, the study design, the study setting, the sample size, the response rate, and the prevalence and risk factors of common mental disorders in pregnant women. Relevant data from each included studies and which fulfill the inclusion criteria were extracted and tabulated. Discrepancies regarding study inclusion and exclusion were resolved through discussion and reaching consensus among the reviewers. The quality of the listed papers was assessed using the Newcastle-Ottawa Scale (NOS) guideline51,52. The Newcastle-Ottawa Scale (NOS) is a widely used tool for evaluating the quality of non-randomised studies, specifically cohort and case-control studies, in systematic reviews and meta-analyses. It was developed by Wells et al. at the University of Ottawa to provide a standardised method for evaluating study quality across three key domains: selection, comparability, and outcome (for cohort studies) or exposure (for case-control studies)52. Agreement beyond chance (unweighted Kappa) and actual agreement were used to evaluate the three reviewers’ agreement. The NOS consists of eight items, grouped into three domains: Selection (4 items) – Evaluates the representativeness of the study population and ascertainment of exposure or outcome. Comparability (1 item) – Assesses whether studies account for key confounders. Outcome/Exposure (3 items) – Assesses the quality of outcome measurement and follow-up (for cohort studies) or ascertainment of exposure (for case-control studies)53. Each item is assigned a star (*) rating, with a maximum of 9 stars for high-quality studies. Selection (max four stars), Comparability (max two stars), and Outcome/Exposure (max three stars). Higher scores indicate better methodological quality, while lower scores suggest a higher risk of bias. Studies scoring 7–9 stars are considered high quality, 4–6 stars are moderate quality, and < 4 stars indicate low-quality studies. The assessments conducted by the reviewers were systematically categorised using predetermined Kappa coefficient values, which serve as a statistical measure of inter-rater reliability by quantifying the degree of agreement between raters beyond what would be expected by chance alone. In this classification, a Kappa value of 0 is interpreted as indicating poor agreement, suggesting no meaningful consensus among reviewers. Values ranging from 0.01 to 0.20 are considered to reflect slight agreement, indicating minimal alignment between assessments. A Kappa value between 0.21 and 0.40 denoted fair agreement, implying a low to moderate level of consistency in evaluations. Moderate agreement is attributed to values between 0.41 and 0.60, demonstrating a reasonable degree of concordance among raters. Substantial agreement is defined within the range of 0.61 to 0.80, signifying strong consistency in reviewer assessments. Lastly, Kappa values between 0.81 and 1.00 were regarded as indicative of almost perfect agreement, representing an exceptionally high level of reliability and uniformity in the evaluations provided54. Data analysis This systematic review and meta-analysis examined the prevalence and risk factors of common mental disorders among pregnant women as reported in the included articles. All statistical analyses were conducted using STATA Statistical Software, version 11 (https:/www.stata.com). This software is used to perform data management, statistical modelling, and inferential analyses, ensuring accuracy and reliability in our findings. The choice of STATA was based on its robust analytical capabilities, including its ability to manage complex survey data, regression analyses, and advanced statistical computations essential for the study. The findings of this meta-analysis are presented using tables, forest plots, and funnel plots for clarity and transparency. Detailed tables summarised key study characteristics such as author, publication year, design, sample size, population, exposure/intervention, outcome measures, effect size estimates with 95% confidence intervals (CIs), and study quality assessments. A separate table provided risk of bias evaluations using standardised tools like the Newcastle-Ottawa Scale (NOS) and Cochrane’s Risk of Bias tool. Forest plots visually displayed individual study effect sizes with 95% CIs, the overall pooled effect estimate, and study weights (calculated by inverse variance). Heterogeneity was assessed using the I² statistic. Separate plots were created for various outcomes and subgroup analyses. Funnel plots assessed publication bias by displaying the distribution of effect sizes against standard errors. Egger’s regression tests were performed to evaluate small-study effects. The trim-and-fill method is applied when needed to adjust for missing studies and provide a more accurate pooled effect size. In the included studies, heterogeneity was quantified by using the I2 statistic55,56. The authors considered I2 values > 50% to represent significant heterogeneity. We used the random effect model to estimate the pooled prevalence and associated risk factors of common mental disorders among pregnant women. Thus, the estimated pooled prevalence and risk factors of CMD are reported in the form of percentages with 95% CI. Furthermore, we conducted a subgroup analysis to explore the potential sources of heterogeneity based on the continents, sample size, and diagnostic tools. We assessed publication bias using both graphical and statistical methods using the funnel plot to visually inspect asymmetry in the distribution of study effect sizes, and Egger’s test, which may indicate potential publication bias. A statistically significant result from Egger’s test (p < 0.05) suggests the presence of asymmetry, which could contribute to publication bias or other factors such as heterogeneity or methodological differences among studies. These methods allowed us to evaluate the potential impact of publication bias on our findings. Additionally, to assess the influence of each study on the overall results, sensitivity analyses were conducted. This involved systematically removing one study at a time from the meta-analysis and recalculating the pooled effect size to determine if the inclusion or exclusion of any single study significantly altered the overall results. Results Selection and characterization of included studies In this systematic review, there is a total of 8546 articles retrieved from online databases using systematic searching. Of these, 8312 articles were excluded due to duplicate records. Of these, 234 articles were eligible for further screening. Among them 123 articles were excluded during the evaluation of their title and abstracts because they did not consistently reflect the intended outcome of interest. The remaining sixty-two articles were eligible for full-text assessment. Of sixty-two eligible articles, forty-four articles were excluded due to did not reporting relevant interest outcomes. Finally, eighteen full-text articles were screened for eligibility and included in this meta-analysis (Fig. 1). PRISMA flow chart shows the selection process of eligible studies for this review, 2020. Overall, the studies included in this review were conducted across three continents: Africa57–63, South America50,64–68, and Asia49,69–72. Large numbers of research papers were found in Africa. Around fifteen included articles were conducted using a cross-sectional study design, two studies used a cohort design, and one study used a case-control study design. The occurrence of CMD was assessed using the Self-Reporting Questionnaire-20 (SRQ-20), Clinical Interview Schedule-Revised (CIS-R), Mini-International Neuropsychiatric Interview (MINI), and Edinburgh Postnatal Depression Scale (EPDS) (Table 1). In the included studies, eighteen studies reported the prevalence of CMD among pregnant women, whereas around nine studies incorporated risk factors of common mental disorder. Table 1Characteristics of the included studies of common mental disorders in pregnant women in the world (n = 18).AuthorsPublication yearContinentStudy populationMean age (years)Study designScaleSample sizePrevalence (%)Response rate (%)Woldetsadik et al., 20192019AfricaPregnant women27.3Cross-sectionalSRQ-2074335.8N/RKurbi et al., 20232023AfricaPregnant women29Cross-sectionalSRQ-2087213.197Tamiru et al., 20222022AfricaPregnant women30.1Cross-sectionalSRQ-201,01537.598.2Dessie et al., 20222022AfricaPregnant women28.9Cross-sectionalSRQ-2077718.199.8Parcesepe et al., 20212021AfricaPregnant women25Cross-sectionalSRQ-2023042N/AAbraham et al., 20172017AfricaPregnant women26.6Cross-sectionalSRQ-2023246.697.9Faisal-Cury et al., 20102010South AmericaPregnant womenN/RCohortCIS-R83133.695.7Usuda et al., 20162016AsiaPregnant womenN/RCross-sectionalMINI3546.259.6Jha et al., 20212021AsiaPregnant women23.9Cross-sectionalMINI45715.390.7Yang et al., 20162016AsiaPregnant womenN/Rcase-controlN/ A665615.877.3Lucchese et al., 20172017AsiaPregnant women24.33Cross-sectionalSRQ-2033057.1N/RKhatri et al., 20182018AsiaPregnant womenN/RCross-sectionalEPDS-N49721.999.8Silva et al., 2022202South AmericaPregnant womenN/RCohortSRQ-2069936.281.3Ludermir et al., 20142014South AmericaPregnant womenN/RCross-sectionalSRQ-2011207198.8Ludermir et al., 20102010South AmericaPregnant womenN/RCross-sectionalSRQ-20112143.198.9Faisal-Cury et al., 20092009South AmericaPregnant women25Cross-sectionalCIS-R83120.295.7Mardenborough-Razack and Gomez-Sponholz, 20232023South AmericaPregnant women26Cross-sectionalSRQ-2020036N/RMohammed et al., 20232023AfricaPregnant womenN/RCross-sectionalSRQ-2041520.598.6*N/R = not reported, *N/A = not applicable. Characteristics of the included studies of common mental disorders in pregnant women in the world (n = 18). *N/R = not reported, *N/A = not applicable. Quality assessment In this systematic review, each included studies evaluated based on the nine criteria of the NOS quality assessment guideline, which evaluates the selection method, comparability, and outcomes of included studies. The quality appraisal indicated consistently strong methodological design in all included studies. The inter-rater reliability was good, with Kappa values ranging from 0.88 to 1, indicating almost perfect agreement between reviewers (Table 2). Table 2Quality assessments of common mental disorders in pregnant women in the world.Author, year of publicationQ1Q2Q3Q4Q5Q6Q7Q8Q9Total score (0–9)Kappa valueLevel of agreementWoldetsadik et al., 2019YYYYYYYN/RY80.88Almost perfectKurbi et al., 2023YYYYYYYYY91Almost perfectTamiru et al., 2022YYYYYYYYY91Almost perfectDessie et al., 2022YYYYYYYYN/R80.88Almost perfectParcesepe et al., 2021YYYYYYYYN/R80.88Almost perfectAbraham et al., 2017YYYYYYYYY91Almost perfectFaisal-Cury et al., 2010YYYYYYYYY91Almost perfectUsuda et al., 2016YYYYYYYYY91Almost perfectJha et al., 2021YYYYYYYYY91Almost perfectYang et al., 2016YYYYYYYYY91Almost perfectLucchese et al., 2017YYYYYYYYY91Almost perfectKhatri et al., 2018YYYYYYYYY91Almost perfectSilva et al., 2022YYYYYYYYY91Almost perfectLudermir et al., 2014YYYYYYYYY91Almost perfectLudermir et al., 2010YYYYYYYYY91Almost perfectFaisal-Cury et al., 2009YYYYYYYYY91Almost perfectMardenborough-Razack and Gomez-Sponholz, 2023YYYYYYYYY91Almost perfectMohammed et al., 2023YYYYYYYYY91Almost perfectKey: Y = Yes; NR = Not reported. Quality assessments of common mental disorders in pregnant women in the world. Key: Y = Yes; NR = Not reported. Question codes: Was the sample frame appropriate to address the target population? Was the sample frame appropriate to address the target population? Were study participants sampled in an appropriate way? Were study participants sampled in an appropriate way? Was the sample size adequate? Was the sample size adequate? Were the study subjects and the setting described in detail? Were the study subjects and the setting described in detail? Was the data analysis conducted with sufficient coverage of the identified sample? Was the data analysis conducted with sufficient coverage of the identified sample? Were valid methods used for the identification of the condition? Were valid methods used for the identification of the condition? Was the condition measured in a standard, reliable way for all participants? Was the condition measured in a standard, reliable way for all participants? Was there appropriate statistical analysis? Was there appropriate statistical analysis? Was the response rate adequate, and if not, was the low response rate managed appropriately? Was the response rate adequate, and if not, was the low response rate managed appropriately? Worldwide estimated pooled prevalence of common mental disorders in pregnant women Based on the random effect model, the estimated pooled prevalence of the common mental disorder among pregnant women in the world was 31.59% (95% CI: 23.74–3943) (Fig. 2). We found significant heterogeneity between studies (I2= 99.3%, P = 0.000). To explore the potential sources of heterogeneity, we did subgroup analysis by geographical location, assessment (diagnostic) tools, and sample size. Forest plot describing the pooled prevalence of common mental disorders among pregnant women in the world with 95% CI. Subgroup analysis by geographic variations Based on a subgroup analysis by geographic location, the result demonstrates that the estimated prevalence of the common mental disorders among pregnant women in Africa was found to be (pooled prevalence = 30.30%; 95% CI: 20.95–39.65), Asia (pooled prevalence = 22.96%; 95% CI: 13.12–32.78), and South America (pooled prevalence = 40.30%; 95% CI: 23.92–59.15) (Fig. 3). Forest Plot describing the sub-group analysis based on continents in the world with 95% CI. Sub-group analysis by diagnostic (assessment) tools A diagnostic tool-based subgroup analysis indicated substantial variation in the estimated prevalence of common mental disorders among pregnant women. Studies employing SRQ-20 reported the highest pooled prevalence (38.05%; 95% CI: 26.82–49.28), followed by those using the CIS-R (26.87%; 95% CI: 13.74–40.00). Lower prevalence estimates were observed in studies conducted utilising the MINI (10.68%; 95% CI: 1.77–19.60), and while investigations categorising under “others” assessment instruments yielded the pooled prevalence of 18.58% (95% CI: 12.63–24.54) (Fig. 4). Forest plot describing the subgroup analysis by diagnostic or assessment tools with 95% CI. *Others* (refers to tools used to measure CMD, which are used only once or not reported at all). Subgroup analysis by sample sizes A subgroup analysis stratified by sample size showed no statistically significant differences in prevalence estimates between studies with fewer than 500 participants (pooled prevalence: 32.42; 95% CI:21.30–43.54) and those including 500 or more participants (pooled prevalence: 30.53%; 95% CI: 18.80–42.26) (Fig. 5). The forest plot of subgroup analysis conducted by sample size, the prevalence of common mental disorders among pregnant women, with 95% CI. Publication bias Based on the visual inspection of the funnel plot, slightly suggested an asymmetrical distribution of studies, indicating a publication bias (Fig. 6). The observation was further supported by Egger’s test, which demonstrated a statistically significant bias coefficient (p = 0.013). Accordingly, the presence of publication bias was inferred, and a trim-and-fill analysis was performed to adjust for its potential impact on the pooled prevalence (Fig. 7). Additionally, the sensitivity analysis was conducted and indicated that no individual study had a significant influence on overall results, confirming the robustness of the findings (Fig. 8). A funnel plot describing visual inspection of the presence of publication bias. Trim and fill analysis of common mental disorders in pregnant women in the world. The sensitivity analysis of common mental disorders in pregnant women. The associated risk factors of common mental disorders in pregnant women Among the eighteen listed studies, this meta-analysis included nine papers that explained the variables linked to factors associated with common mental disorders in pregnant women. In this review, the incorporated risk factors for common mental disorders were family history of mental health condition, intimate partner violence, chronic medical condition, emotional violence, a history of abortion, and unplanned pregnancy. However, only intimate partner violence (POR = 2.63; 95% CI: 1.12, 6.17) was found to be a significant risk factor for common mental disorders among pregnant women (Fig. 9). Factors associated with common mental disorders in pregnant women in the world. Discussion This systematic review and meta-analysis aimed to assess the prevalence and risk factors of common mental disorders (CMD) among pregnant women globally. The research team conducted a comprehensive and systematic review of published literature with no temporal restrictions. This study incorporated evidence from multiple study designs, including cross-sectional, cohort, and case-control studies. Different validated assessment tools, such as the Self-Reporting Questionnaire-20 (SRQ-20), Clinical Interview Schedule-Revised (CIS-R), Mini-International Neuropsychiatric Interview (MINI), and Edinburgh Postnatal Depression Scale (EPDS), utilized to measure CMD. Furthermore, a subgroup analysis conducted to explore variations in CMD prevalence across different regions and measurement tools. From this meta-analysis, the global estimated prevalence of CMD in pregnant women found to be 31.59%. This estimate aligns closely with findings from previous meta-analyses, which reported CMD prevalence rates of 29.2%16, 36.43%73, and 31.0%74. These consistent results reinforce the notion that CMD is one of the prevalent health concerns among pregnant women worldwide. However, when compared with studies conducted in specific regions, we observed the differences on the prevalence of CMD among pregnant women. For instance, the reported prevalence in South Asian countries was 14.2%75, while a meta-analysis focusing on among women during the antenatal care and adolescents estimated a prevalence of 15.0% and 13.4%38,76, and a study conducted in Uganda reported a prevalence of 22.9%77. Factors could contribute to these discrepancies, including variations in the study population, methodological differences, cultural and contextual influences, and the socio-demographic characteristics of the participants. To explore the existing potential sources of heterogeneity and publication bias the subgroup analyses were conducted to examine CMD prevalence by continent, sample sizes, and measurement tools. The findings indicated that CMD prevalence was highest in South America compared to Africa and Asia. This suggests that geographical and socio-economic factors may play a significant role in shaping the mental health status of pregnant women. Additionally, when CMD prevalence analyzed based on the measurement tools used, there was a consistent prevalence pattern observed in studies that used SRQ-20 and CIS-R, highlighting the reliability of these instruments in assessing CMD in this population. Among the various risk factors explored, intimate partner violence (IPV) emerged as a significant predictor of CMD in pregnant women. This finding is consistent with previous research, reinforcing the well-documented link between IPV and adverse mental health outcomes78. A plausible explanation for this association is that experiencing physical, psychological, or sexual violence during pregnancy can lead to feelings of hopelessness, helplessness, guilt, low self-esteem, and depression. The heightened stress and emotional distress resulting from IPV can significantly contribute to the development or exacerbation of CMD during pregnancy. Despite the valuable insights provided by this systematic review and meta-analysis, certain limitations should acknowledge. First, the included studies limited to those published in English, which may have resulted in the exclusion of relevant research published in other languages. This language restriction could have led to a partial representation of the global prevalence of CMD in pregnant women. The research team acknowledged that the high level of heterogeneity among the included studies, together with potential publication bias, may undermine the internal validity and methodological rigor of the review. Additionally, this review focused exclusively on pregnant women, meaning that its findings cannot generalized to all women of reproductive age. Future research should consider a broader population scope to better understand CMD prevalence and risk factors beyond pregnancy. In conclusion, this systematic review and meta-analysis highlight the significant global burden of CMD among pregnant women, emphasizing the need for targeted mental health interventions. The study underscores the importance of addressing risk factors such as IPV and calls for further research to explore additional socio-cultural determinants of CMD. Addressing these issues through early screening, intervention programs, and policy initiatives could improve maternal mental health outcomes worldwide. Conclusions This study highlights a substantial global burden of common mental disorders among pregnant women, with significant regional variations. The highest prevalence observed in South America, followed by Africa and Asia, indicating the need for region-specific mental health strategies. Additionally, intimate partner violence emerged as a major risk factor, significantly increasing the likelihood of mental health disorders during pregnancy. To address this growing concern, it is crucial to integrate routine mental health screening into maternal healthcare services. Moreover, developing and implementing effective prevention and intervention programs for intimate partner violence within antenatal care settings can help reduce its detrimental impact on maternal mental health and overall pregnancy outcomes. Strengthening healthcare systems, raising awareness, and providing psychosocial support are essential steps toward ensuring better mental health and well-being for pregnant women worldwide. Author contributions TT designed the review idea on the prevalence and associated factors of psychiatric comorbidity among people with epilepsy and outlined the search strategies and the analysis of the research. TT, WG, and SS extract the data from included studies. SS, SK, and WG assessed the quality of the included studies. TT, SS, and SK data analysis. TT writes the manuscript’s first draft. GM, SF, GT, GN, FA, and GR editing and revising the manuscript. All authors reviewed the last version of the review manuscript and approved it. Data availability The main parts of the data generated during this study included in this article. Other data will be available from the corresponding author upon request. Declarations Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The main parts of the data generated during this study included in this article. Other data will be available from the corresponding author upon request.